Table 4. Risk of Retinal Vascular Occlusive Diseases in Control and ACS Cohorts according to LDL-C Strata in the Established Cohort from the National Health Insurance Service Database of South Korea.
| Group | N of events | PY per 100,000 | IR (95% CI) | Adjusted HR† (95% CI) | |
|---|---|---|---|---|---|
| LDL-C control after ACS* | |||||
| LDL-C<55 | 89 | 18093.46 | 491.89 (389.70–594.08) | 1.00 | |
| 55≤LDL-C<70 | 56 | 11508.99 | 486.57 (359.12–613.99) | 1.02 (0.85–1.23) | |
| 70≤LDL-C<100 | 717 | 128029.09 | 560.02 (519.02–600.62) | 1.02 (0.86–1.22) | |
| 100≤LDL-C | 313 | 48605.65 | 643.95 (572.66–715.24) | 1.24 (1.02–1.50) | |
ACS, acute coronary syndrome; PY, person-years; CI, confidence interval; HR, hazard ratio; LDL-C, low-density lipoprotein cholesterol.
*All units of LDL-C are expressed in mg/dL; †Adjusted for age, sex, body mass index, income, mortality, smoking, alcohol consumption, total cholesterol, systolic blood pressure, fasting glucose, and history of atrial fibrillation.